Professionals 243 Users Online

Hospital Acquired Infection Control Market

Rising Demand for Effective Infection Control Measures to Drive Hospital Acquired Infection Control Market Growth

Hospital Acquired Infections Control Market by Product (Heat Sterilization Equipment, Dry Heat Sterilization Equipment, Low Temperature Sterilization Equipment, Radiation Sterilization Equipment, Disinfection Equipment)

Hospital Acquired Infection Control Market Outlook (2023 to 2033)

Worldwide revenue from the Hospital Acquired Infection Control Market stands at US$ 6.6 Billion in 2022, with the global market estimated to expand at a CAGR of 3.9% to reach US$ 10.1 Billion by the end of 2033.

Attributes Key Insights

Hospital-Acquired Infection Control Market Size (2022)

US$ 6.6 Billion

Projected Market Value (2033)

US$ 10.1 Billion

Global Market Growth Rate (2023 to 2033)

3.9% CAGR

Market Share of Top 5 Countries

58.12%

As assessed by Persistence Market Research, disinfection equipment will contribute the largest share of 50.3% among the product category in 2023. The hospital acquired infection control market holds 26.9% of the global hospital acquired infection market valued at US$ 24.55 Billion in 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Hospital Acquired Infection Control Market from 2012 to 2022 Vs Market Outlook for 2023 to 2033

The global market for hospital-acquired infection control recorded a historic CAGR of 4.8% in the last 10 years from 2012 to 2022.

The healthcare infrastructure has changed significantly over the past ten years as a result of the increased adoption of cutting-edge medical technology. The need for disinfection and sterilising equipment has expanded more than ever in the past 10 years as the prevalence of several infectious and chronic diseases has increased.

Rising public awareness of healthcare-associated infections, government programmes to strengthen infection control systems at various medical facilities, and an increase in the prevalence of infectious and communicable diseases are some of the factors that are predicted to drive demand for hospital-acquired infection control technology.

Through 2022 to 2033, sales of infection control equipment sales are anticipated to grow at a CAGR of 3.9%.

To control hospital-acquired infections (HAI), WHO has released the following guidelines:

  • According to research, the best way for enhancing practises is the WHO multimodal hand hygiene enhancement plan. Programs to enhance hand hygiene can stop up to 50% of illnesses that can be prevented during the provision of medical care and, on average, save 16 times as much money as they cost to implement.

The WHO declared the COVID-19 outbreak a public health emergency of global concern on January 30, 2020. COVID-19 has had an impact on 210 different nations worldwide.

The coronavirus infection spread due in part to hospital acquired illnesses since there were insufficient controls in place, and it did so at a level that was never predicted or imagined. The majority of the cases of COVID-19 among medical personnel were brought on by contact and infection transmission within hospitalized patients.

Hospital acquired infections received a lot more attention after the pandemic's seriousness was apparent, and numerous controls were put in place to reduce infections. As a result, hospital acquired infection control equipment was in extremely high demand. Hence, the COVID-19 infection provided new opportunities for producers of infection control products used in hospitals.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

How are Manufacturers Expanding Their Markets?

“Rising Awareness about Personal Hygiene Will Drive Market”

By the end of the decade, the total number of surgical procedures scheduled to be performed annually is predicted to hit a new high. The demand for surgical instruments is expected to expand along with the number of surgical procedures performed, increasing the risk of healthcare-associated infections.

The demand for nosocomial infection control equipment is expected to increase as people become more aware of the benefits of sterilised and disinfected medical equipment. Other variables that will propel sales of hospital acquired infection control systems include the increased incidence of chronic diseases and the developments in surgical technology.

The major players in the market are concentrating on maximising their income potential globally and are attempting to do this by implementing a variety of growth tactics as follows:

  • PURioLABS, a Texas-based business, is revolutionising infection control. PURioLABS is the name given to the company's new portable disinfection cabinet. This innovative cabinet removes bacteria and pathogens from routinely used medical equipment and instruments in a matter of seconds.
  • In April 2021, Unimech Healthcare, a part of Unimech Aerospace and Manufacturing, announced the introduction of its innovative disinfection systems and solutions. The new line, UniClean, has UVGI technology and operates via the cloud.

Moreover, the need for minimally invasive procedures is also rising, and the rise of outpatient services and ambulatory surgery facilities both contribute to this growth. Additionally, because of growing public awareness of health issues and government measures to offer ambulatory healthcare services, the number of outpatients has expanded dramatically.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

How is Market Progress Being Affected to Some Extent?

“The Prevalence of Infectious Diseases”

The prevalence of infectious diseases has a significant influence on the healthcare sector as a whole, which has a significant impact on the demand for hospital acquired infection control equipment.

Hospital-acquired infection control processes and methods have been described as complicated, and in most cases, this is accurate because it necessitates the employment of cutting-edge technologies and tools. Endoscopes are one example of a medical instrument that should be sterilised more thoroughly because of the possibility of nosocomial infections, which could lead to additional patient difficulties.

Despite the fact that sterilisation and disinfection technologies have significantly improved over time, there are currently not enough of these services available to guarantee the security of reprocessed devices in use. Reprocessing technology poses a significant obstacle to preventing hospital-acquired infections, which could potentially restrict market expansion to some extent.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the Hospital Acquired Infection Control Market Booming in the United States?

“Developed Healthcare Infrastructure in the United States”

The United States is set to account for a 33.9% share of the global market in 2023, and a similar trend is expected over the forecast period.

For infection control equipment purchased by hospitals, the United States is a very lucrative industry. The country has a strong healthcare system that is constantly evolving. In the United States, there is a significant need for infection control due to high healthcare costs and widespread public awareness of the issue. The United States is thus anticipated to generate the majority of the region's revenue.

Following is one of the surveys, which were conducted in the United States

  • According to an overview on healthcare associated infections in 2018, in 183 United States hospitals with 11,282 patients, 4% of patients had at least one Hospital Acquired Infection, with Clostridium difficile being the most frequent bacteria. The most common infections were pneumonia, gastrointestinal infections, and surgical site infections (SSIs).

Why is China Emerging as a Prominent Market for Hospital Acquired Infection Control?

“Raising Public Awareness”

China held a market share of around 5.5% of the global market for hospital acquired infection control in 2022, with a market value of US$ 362.9 Mn.

  • According to the data published in the journal of thoracic diseases (JTD) The two most typical hospital-acquired illnesses in China are ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP). High mortality is caused by the challenge of diagnosing and treating HAP/VAP.

The primary drivers of market expansion include raising public awareness of hospital-acquired infections (HAIs), government programmes to support infection control, and an increase in the number of hospital acquired infections. China is expected to dominate in terms of revenue share, owed to the above-mentioned factors.

Why Should Hospital Acquired Infection Control Equipment Suppliers Focus on India?

“Ongoing Development in Healthcare System”

India held a global share of 3.4% in 2022. The second-most populous country in the world is India, and as a result of this, the country's healthcare industry has a lot of potential. It is a particularly profitable market for major suppliers of hospital-acquired infection control equipment due to the nation's ongoing healthcare system development.

As hygiene awareness grows and attention to healthcare intensifies, India is likely to experience a large growth in demand for disinfection equipment. Over the next ten years, it is anticipated that India's healthcare infrastructure would develop and advance more quickly, which will be very advantageous for local market players.

Category-wise Insights

Why is the Market Share for Disinfection Equipment high in the Global Market?

“Rising Cases of Chronic and Infectious Diseases”

Disinfection equipment dominates the global market and is set to old 50.3% market share in the product segment in 2023.

Due to the rise in the number of healthcare facilities & clinics, the ageing population, and the rise in incidences of chronic diseases, the hospitals & clinics sector is the largest participant in the hospital-acquired infection control market among end users.

The number of surgical procedures performed in hospitals is growing daily, which causes the prevalence of hospital-acquired infections to rise. This results in a leading market share for disinfection equipment.

What is the Outlook for Various End Use Applications of Hospital Acquired Infection Control Equipment?

“Increase in the Number of Surgical Procedures”

The hospital sector is anticipated to have the highest demand for hospital acquired infection control systems, and it is anticipated to continue to account for a significant portion of revenue. The segment currently will account for almost 32.1% share in the global market in 2023.

Due to an increase in the number of surgical procedures performed in hospitals, an increase in the prevalence of hospital-acquired infections, an increase in the number of hospitals and clinics, and an increase in the elderly population along with an increase in the prevalence of chronic diseases, hospitals are the largest end-user in the hospital-acquired infection control market.

Competitive Landscape

Healthcare-associated infections have drawn a lot of attention due to an increase in their incidence because of significant changes the industry has seen in recent years. With new launches and strengthened research and development, key businesses are attempting to maximise their market potential in an effort to outperform rivals.

The hospital acquired infection control management has been defined as a highly fragmented field due to the existence of a significant number of industry operators.

For instance :

  • UVision360 Inc. stated in July 2021 that it has been given permission to expand reprocessing practices for use with the LUMINELLE DTx System.
  • In June 2021, STERIS plc purchased Cantel Medical, a leading supplier of products and services for infection control to endoscopy, dental, dialysis, and life sciences clients.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the hospital acquired infection control market, which are available in the full report.

Hospital Acquired Infection Control Market Report Scope

Attribute Details

Forecast Period

2023 to 2033

Historical Data Available for

2012 to 2022

Market Analysis

  • USD Million for Value
  • Units for Volume

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC Countries
  • North Africa
  • South Africa

Key Market Segments Covered

  • Product
  • End User
  • Region

Key Companies Profiled

  • Olympus Corporation,
  • Medivators Inc. (Cantel Medical Corp.),
  • Getinge Group,
  • STERIS Plc.,
  • Belimed AG (Metall Zug),
  • Steelco S.P.A,
  • Pfizer Inc.,
  • F. Hoffmann-La Roche Ltd,
  • Merck & Co.,
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson),
  • Abbott Laboratories,
  • Bayer AG,
  • Alere Inc.,
  • The 3M Company,
  • Cepheid Inc.
  • UVision360 Inc.

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments of the Hospital Acquired Infection Control Market

By Product :

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
    • Disinfector
      • Washer Disinfector
      • Flusher Disinfector
    • Endoscopic Reprocessor Systems
      • Single Basin Endoscopic Reprocessor Systems
      • Dual Basin Endoscopic Reprocessor Systems
    • Disinfectants

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Olympus Corporation
  • Medivators Inc. (Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG (Metall Zug)
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co.
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc
  • UVision360 Inc.

- Frequently Asked Questions -

The global market for hospital acquired infection control is valued at around US$ 6.6 Bn in 2022.

By 2033, sales of hospital acquired infection control are anticipated to expand at a pace of 3.9 % and reach US$ 10.1 Bn.

Demand for hospital acquired infection control increased at 4.8% CAGR from 2012 to 2022.

With a combined market share of 58.12% in 2022, the U.S., Germany, France, China, and Canada accounted for the majority of demand for hospital acquired infection control.

The U.S. will account for a 33.9% share of the global market in 2023.

Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), and Getinge Group are the top three manufacturers of the hospital acquired infection control market.

China held a share of 5.50 % in the global market in 2022.

The market for hospital acquired infection control in UK is set to grow with a CAGR of close to 3.8% over the forecast period.

In 2022, India held a market share of 3.4% globally for the market of hospital acquired infection control.

The European market holds 28.6% revenue share globally for the market of hospital acquired infection control.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate